Dr. Reddy's in talks to buy UCB's Indian biz; Boehringer loses Indian patent on COPD med Spiriva;

@FiercePharma: Bayer puts cancer-fighting country crooner onstage to promote colonoscopies. FiercePharmaMarketing article | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: MS Pharma in Jordan gets $30M development loan to expand its drug manufacturing. Story | Follow @EricPFierce

@CarlyHFierce: ICYMI: GSK sacks 100-plus China workers for misconduct in wake of bribery scandal. Report | Follow @CarlyHFierce

> India's Dr. Reddy's is said to be in talks to buy Belgium-based UCB's Indian operations for $135 million. Report

> Germany's Boehringer Ingelheim lost its Indian patent on the lung drug Spiriva, as the country's patent office sided with Cipla in a patent challenge. Report

> Sanofi ($SNY) tapped Robert Castaigne to chair its audit committee, replacing Dr. Klaus Pohle, who'll remain on the board; Castaigne, who was Total's CFO till 2008, has served as a Sanofi director since 2000. Release

> Portola Pharmaceuticals, which is developing an antidote to a new generation of anticoagulant drugs, expects to raise $100 million in a stock offering priced Tuesday. Release

> The FDA released new documents to provide a roadmap for companies developing generic versions of 38 drugs, including newer meds Kalydeco, from Vertex Pharmaceuticals ($VRTX), and Imbruvica, sold by Johnson & Johnson ($JNJ) and Pharmacyclics ($PCYC). Report

> Actavis ($ACT) rolled out its generic version of Temovate, a topical steroid marketed by Fougera. Report

Medical Device News

@FierceMedDev: Exact Sciences signs on Anthem and Aetna to noninvasive colon cancer Dx. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: FDA approves novel blood purifier that treats rare condition in hemodialysis patients. Report | Follow @VarunSaxena2

@EmilyWFierce: Check out FierceBiotech Radio's latest podcast with Express Scripts CMO Steve Miller on iTunes. | Follow @EmilyWFierce

> Veniti raises $17M to complete pivotal venous stent trial aimed at FDA approval. News

> Apple announces open-source data-collection platform for mobile medical apps. Story

> Study: FDA-cleared biomarker can reduce ADHD overdiagnosis. Article

Biotech News

@FierceBiotech: FierceBiotech Radio with Express Scripts' Steve Miller. More | Follow @FierceBiotech

@JohnCFierce: Biopharma's new normal: Constant makeovers leave R&D jobs at permanent risk. Editor's corner | Follow @JohnCFierce

@DamianFierce: Hey @FierceBiotech's podcast is now available on Stitcher. If you know what that means, here you go. | Follow @DamianFierce

> Collegium bags $50M to get its abuse-deterrent painkiller through the FDA. News

> FDA panel backs Kythera's double chin-fighting shot. Story

> Eyeing an FDA filing, Ocular Therapeutix drug hits PhIIIa goals. Article

Biotech Research News

> Mouse model for rheumatoid arthritis responds to M-MDSCs. Item

> Salk scientists use new CRISPR tech to chop up HIV. More

> Activating thyroid hormone receptor may rev up metabolism. Story

> UC Berkeley team puts its heart into latest organ-on-a-chip project. Article

> Mayo/Scripps team begins testing a new class of anti-aging drugs. Report

Pharma Manufacturing News

> Sun's buyout of Ranbaxy gets India's approval. Item

> U.S. biotech buying Belgium cell manufacturer for $25M. News

> Hospira recalls more saline as well as drug used during pregnancy. Report

> Patheon strikes again; deal for Agere its second in a week. Story

> Recro picks up Alkermes plant, pain drugs and contract biz. Article

Pharma Asia News

> Boehringer Spiriva patent revoked in Cipla challenge in India. Item

> SK Chemicals gets Korea nod for cell-culture flu vaccine 'SKYCellflu.' Report

> Japan's R-Tech Ueno evaluates options as PhIII candidate Unoprostone fails primary endpoint. More

> Sun and Ranbaxy now a couple as last hurdle cleared for India's top drug company. Story

> Sri Lanka poised to launch mandatory generics-first policy. Article

And Finally... A growing number of breast cancer patients are freezing their scalps to preserve their hair during chemo treatment. Report

Suggested Articles

Sixteen years after it was approved, the FDA has ordered that heartburn drug Zantac and its generics be removed from the market.

In a non-randomized study in China, Avigan cleared virus after a median 4 days, significantly shorter than the 11 days observed for AbbVie's Kaletra.

Pfizer's 1.1-million-square-foot sterile injectables plant in Visakhapatnam has been criticized by the FDA for poor quality testing.